ZVSA
ZyVersa Therapeutics Inc

4,946
Mkt Cap
$1.79M
Volume
3,180.00
52W High
$1.67
52W Low
$0.11
PE Ratio
-0.06
ZVSA Fundamentals
Price
$0.2001
Prev Close
$0.221
Open
$0.2367
50D MA
$0.2225
Beta
-0.34
Avg. Volume
12,002.90
EPS (Annual)
-$4.18
P/B
-0.14
Rev/Employee
$0.00
$0.695
Loading...
Loading...

About

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Weston, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6

Frequently Asked Questions

What is Market Cap of ZyVersa Therapeutics Inc?
What is the 52-week high for ZyVersa Therapeutics Inc?
What is the 52-week low for ZyVersa Therapeutics Inc?
What is ZyVersa Therapeutics Inc stock price today?
What was ZyVersa Therapeutics Inc stock price yesterday?
What is the PE ratio of ZyVersa Therapeutics Inc?
What is the Price-to-Book ratio of ZyVersa Therapeutics Inc?
What is the 50-day moving average of ZyVersa Therapeutics Inc?
How many employees does ZyVersa Therapeutics Inc have?

Latest ZVSA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.